Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.1.1.205 extracted from

  • Patel, C.G.; Richman, K.; Yang, D.; Yan, B.; Gohh, R.Y.; Akhlaghi, F.
    Effect of Diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipients (2007), Ther. Drug Monit., 29, 735-742.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine in stable kidney transplant recipients, inosine 5'-phosphate dehydrogenase activity is 17.5 versus 46.6 nmol XMP/h/microgramm protein in diabetic and nondiabetic patients, respectively. Activity in diabetic patients is significantly lower irrespective of concomitant therapy with cyclosporine or tacrolimus and independent of the bound or unbound mycophenolic acid Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
stable kidney transplant recipients
-